Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65026 - 65050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	ESR2	2100	upregulated	resveratrol results in increased expression of ESR2 mRNA	14q23.2-q23.3	A23885 A20265
Resveratrol	Investigational	ETNK2	55224	upregulated	resveratrol results in increased expression of ETNK2 mRNA	1q32.1	A22289
Resveratrol	Investigational	EZH1	2145	upregulated	resveratrol results in increased expression of EZH1 mRNA	17q21.2	A22498
Resveratrol	Investigational	EZH2	2146	upregulated	resveratrol results in increased expression of EZH2 mRNA	7q36.1	A23851
Resveratrol	Investigational	F3	2152	downregulated	resveratrol results in decreased expression of F3 mRNA	1p21.3	A23934 A23778
Resveratrol	Investigational	FABP7	2173	upregulated	resveratrol results in increased expression of FABP7 mRNA	6q22.31	A22498
Resveratrol	Investigational	FAM107A	11170	downregulated	resveratrol results in decreased expression of FAM107A mRNA	3p14.3-p14.2	A22289
Resveratrol	Investigational	FAM107B	83641	downregulated	resveratrol results in decreased expression of FAM107B mRNA	10p13	A21103
Resveratrol	Investigational	FAM222B	55731	downregulated	resveratrol results in decreased expression of FAM222B mRNA	17q11.2	A21103
Resveratrol	Investigational	FAM43A	131583	downregulated	resveratrol results in decreased expression of FAM43A mRNA	3q29	A21103
Resveratrol	Investigational	FAS	355	upregulated	resveratrol analog results in increased expression of FAS mRNA	10q23.31	A23915
Resveratrol	Investigational	FAS	355	upregulated	resveratrol results in increased expression of FAS mRNA	10q23.31	A23872 A23867
Resveratrol	Investigational	FASLG	356	upregulated	resveratrol analog results in increased expression of FASLG mRNA	1q24.3	A23915
Resveratrol	Investigational	FASLG	356	upregulated	resveratrol results in increased expression of FASLG mRNA	1q24.3	A23868 A23935
Resveratrol	Investigational	FASN	2194	downregulated	resveratrol results in decreased expression of FASN mRNA	17q25.3	A23876
Resveratrol	Investigational	FBLN5	10516	upregulated	resveratrol results in increased expression of FBLN5 mRNA	14q32.12	A23852
Resveratrol	Investigational	FBXO32	114907	downregulated	resveratrol results in decreased expression of FBXO32 mRNA	8q24.13	A23852
Resveratrol	Investigational	FBXO32	114907	upregulated	resveratrol results in increased expression of FBXO32 mRNA	8q24.13	A23936
Resveratrol	Investigational	FDFT1	2222	upregulated	resveratrol results in increased expression of FDFT1 mRNA	8p23.1	A23937
Resveratrol	Investigational	FDXR	2232	upregulated	resveratrol results in increased expression of FDXR mRNA	17q25.1	A23852
Resveratrol	Investigational	FGF1	2246	upregulated	resveratrol results in increased expression of FGF1 mRNA	5q31.3	A21627
Resveratrol	Investigational	FGF2	2247	downregulated	resveratrol results in decreased expression of FGF2 mRNA	4q28.1	A23938
Resveratrol	Investigational	FGF21	26291	upregulated	resveratrol results in increased expression of FGF21 mRNA	19q13.33	A23939
Resveratrol	Investigational	FGF4	2249	downregulated	resveratrol results in decreased expression of FGF4 mRNA	11q13.3	A23863
Resveratrol	Investigational	FGFR1	2260	upregulated	resveratrol results in increased expression of FGFR1 mRNA	8p11.23	A22498

Displaying entries 65026 - 65050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability